The University of Nebraska Medical Center is seeking participants for
a research study that will investigate the effectiveness of an experimental
therapy for multiple sclerosis attacks.
Patients with multiple sclerosis may qualify for the study. MS attacks
include the onset of a new symptom or the sudden worsening of a previous
symptom, such as weakness, trouble walking, dizziness, loss of coordination,
numbness or vision loss.
The investigational treatment used in this study is administered
shortly after the start of an MS attack.
Patients with multiple sclerosis who know they are experiencing
an MS attack that started within the past 24 hours can contact the UNMC
hospital operator at (402) 559-4000 and ask the operator to page #2637
for immediate assistance.
For more information and to determine eligibility for the study,
call (402) 559-7857 any time of the day.
UNMC is the only public academic health science center in the state.
Through its commitment to research, education and patient care, UNMC has
established itself as one of the country’s leading centers for cancer research
and treatment and solid organ transplantation. More than $34 million in
research grants and contracts are awarded to UNMC scientists annually.
In addition, UNMC’s educational programs are responsible for training more
health professionals practicing in Nebraska than any other institution.